Is BRSHF or JNJ a better dividend investment in 2026?

BRSHF currently yields 1000000.00% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: BRSHF offers higher current income.

What is the dividend yield difference between BRSHF and JNJ?

BRSHF has a forward dividend yield of 1000000.00% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 999997.87 percentage points.

Home › Compare › BRSHF vs JNJ

BRSHF vs JNJ: Dividend Comparison 2026

BRSHF yields 1000000.00% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BRSHF wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BRSHF

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full BRSHF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — BRSHF vs JNJ

📍 BRSHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BRSHF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BRSHF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BRSHF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRSHF

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, BRSHF beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRSHF + JNJ for your $10,000?

BRSHF: 50%JNJ: 50%

100% JNJ50/50100% BRSHF

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BRSHF

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRSHF buys

JNJ buys

No recent congressional trades found for BRSHF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBRSHFJNJ

Forward yield	1000000.00% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$4.7683925249533696e+36M	$30.3K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$4,689.40
Total dividends collected	$4.7683311610149396e+36M	$15.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: BRSHF vs JNJ ($10,000, DRIP)

Year	BRSHF Portfolio	BRSHF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$10,592	$272.30	+$100.00M → BRSHF
2	$934,786,450,701	$934,679,439,252.34	$11,289	$357.73	+$934786.44M → BRSHF
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$12,123	$472.89	+$8165787108.57M → BRSHF
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$13,141	$629.86	+$66665884190957.63M → BRSHF
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$14,408	$846.81	+$508662171058048128.00M → BRSHF
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$16,021	$1,151.60	+$3.62723524842849e+21M → BRSHF
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$18,122	$1,588.22	+$2.417368115915061e+25M → BRSHF
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$20,930	$2,228.20	+$1.5056740286145463e+29M → BRSHF
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$24,792	$3,191.91	+$8.764771002818475e+32M → BRSHF
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$30,274	$4,689.40	+$4.7683925249533696e+36M → BRSHF

BRSHF vs JNJ: Complete Analysis 2026

BRSHF — Stock

Bruush Oral Care Inc., an oral care company, manufactures and sells electric toothbrushes in the United States and Canada. It offers Brüush starter kit, including electric toothbrush, three brush heads, a magnetic charging stand and USB power adapter, and a travel case. It also provides brush head refills. The company sells its products through its website www.bruush.com. Bruush Oral Care Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Full BRSHF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this BRSHF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRSHF vs SCHD BRSHF vs JEPI BRSHF vs O BRSHF vs KO BRSHF vs MAIN BRSHF vs ABBV BRSHF vs MRK BRSHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.